Description: Nuwellis, Inc. is a medical device company dedicated to changing the lives of patients suffering from fluid overload through science, collaboration, and innovation. The Company is focused on developing, manufacturing and commercializing the Aquadex SmartFlow® System for ultrafiltration therapy. Nuwellis is headquartered in Minneapolis, Minn., with a wholly-owned subsidiary in Ireland. The Company has been listed on the Nasdaq Capital Market since February 2012, previously branded as CHF Solutions.
Home Page: www.nuwellis.com
NUWE Technical Analysis
12988 Valley View Road
Eden Prairie,
MN
55344
United States
Phone:
952 345 4200
Officers
| Name | Title |
|---|---|
| Mr. Nestor Jaramillo Jr. | Pres, CEO & Director |
| Mr. Neil P. Ayotte Esq. | Sr. VP, Gen. Counsel, Sec. & Chief Compliance Officer |
| Ms. Lynn L. Blake CPA, M.B.A. | Chief Financial Officer |
| Mr. Rob Scott | Sr. Director of Financial Planning & Analysis and Interim Principal Accounting Officer |
| Mr. William Colon M.D. | VP of Marketing |
| Mr. John Kowalczyk | VP of Sales |
| Ms. Sandra Eayrs | Chief HR Officer |
| Mr. Vitaliy Epshteyn | Sr. VP of Operations & Engineering |
| Mr. Paul Wotta | Corp. Controller |
| Mr. Laurent Duhoux | VP of International Bus. Devel. |
Exchange: NASDAQ
Country: US : United States of America
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.27 |
| Price-to-Sales TTM: | 0.3223 |
| IPO Date: | 2012-02-16 |
| Fiscal Year End: | December |
| Full Time Employees: | 70 |